Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Drug Discovery

Background:

• Cardiac diseases are a leading global cause of mortality with limited therapeutic progress.
• Traditional animal models for cardiac disease research present species-specific limitations, impacting drug safety and efficacy.
• Human pluripotent stem cell (hPSC) technology provides a scalable source of human cardiac cells.

Purpose of the Study:

• To review the applications of hPSCs in cardiac disease modeling.
• To discuss the potential of hPSCs in cell therapy for heart conditions.
• To explore the role of hPSCs in next-generation drug discovery for cardiovascular diseases.

Main Methods:

• Utilizing hPSC-derived cardiac cells in various culture systems, including 2-D monocultures.
• Applying hPSC-derived cells in advanced platforms like 3-D organoids, tissue engineering, and heart-on-a-chip models.
• Reviewing current literature on hPSC applications in cardiovascular research and therapeutics.

Main Results:

• hPSC-derived cells are adaptable to both simple and complex experimental systems.
• These cells show potential for more accurate prediction of drug responses compared to animal models.
• hPSC technology offers a renewable source for studying diverse cardiac conditions.

Conclusions:

• hPSC technology holds significant promise for advancing cardiovascular medicine.
• Further optimization of hPSC-related technologies is needed for widespread clinical and research application.
• hPSCs are poised to revolutionize cell-based therapies and drug discovery for heart diseases.